Bolak Co

Bolak Co EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Bolak Co (002760.KS) as of Nov 3, 2026 is 2.23 B KRW. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -1.56 B KRW — a change of -242.69% (higher).

EBITDA

2.23 BKRW

YoY

-242.69%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Bolak Co is 2025 2.23 B KRW. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Bolak Co was 2024 -1.56 B KRW. It decreases by -242.69% higher compared to the previous year.

The Bolak Co EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
1.39 B KRW
Jan 1, 2019
856.57 M KRW
Jan 1, 2020
562.48 M KRW
Jan 1, 2021
2.15 B KRW
Jan 1, 2022
3.66 B KRW
Jan 1, 2023
1.03 B KRW
Jan 1, 2024
-1.56 B KRW
Jan 1, 2025
2.23 B KRW
The Bolak Co EBITDA history
YEAREBITDAYoY
2.23 BKRW-242.69%
-1.56 BKRW-252.36%
1.03 BKRW-71.98%
3.66 BKRW+69.90%
2.15 BKRW+283.12%
562.48 MKRW-34.33%
856.57 MKRW-38.42%
1.39 BKRW+0.79%
1.38 BKRW-37.13%
2.20 BKRW+47.18%
1.49 BKRW-33.96%
2.26 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bolak Co Stock analysis

What does Bolak Co do? Bolak Co., Ltd. generates revenue through its two core business divisions: food additives and pharmaceutical ingredients. The food additives division produces flavors, colors, botanical extracts, nutraceuticals, white emulsion, antioxidants, emulsifiers, bleaching agents, acidulant, and sweetness products. The pharmaceutical ingredients division manufactures extract powers, fluid extracts, tinctures, protein concentrates, and calcium carboxymethyl cellulose (CMC). Domestic and overseas markets purchase these products, with the company distributing them across both regions. The firm's product portfolio targets food manufacturers and pharmaceutical companies seeking raw materials for their production processes. Bolak Co., Ltd. serves food manufacturers and pharmaceutical companies as its primary customer segments. These segments require specialized ingredients for their product development and production lines. The company's domestic market includes Korean food and pharma firms, while overseas buyers include international food processors and pharmaceutical producers. The firm's product range supports both the food and pharmaceutical industries through direct sales to these end-users. The company's revenue streams are derived from the sale of its manufactured ingredients, with no mention of additional services or licensing. Food additives like white emulsion and antioxidants are sold to food producers, while pharmaceutical ingredients such as protein concentrates and CMC are supplied to drug manufacturers. The business model relies on consistent demand for these raw materials from established industry clients. Bolak Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bolak Co stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Bolak Co is 2.23 B KRW in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Bolak Co changed from -1.56 B KRW to 2.23 B KRW, representing a -242.69% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Bolak Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Bolak Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Bolak Co

All Key Metrics — Bolak Co